Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5172
Revised: April 19, 2011
Accepted: April 26, 2011
Published online: December 21, 2011
AIM: To compare culture analysis, Helicobacter pylori (H. pylori) stool antigen (HpSA) test, polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH) for H. pylori detection.
METHODS: One hundred and thirty-two consecutive adult dyspeptic patients receiving diagnostic endoscopy at the department of gastroenterology were enrolled in this study. Culture and histological examination were performed on biopsy specimens. PCR and FISH tests were applied to histopathological samples. Stool samples that were simultaneously collected were tested for the H. pylori antigen using the HpSA test and bacterial DNA using stool PCR.
RESULTS: H. pylori was positively identified by histological examination in 85/132 (64.4%) of the patients, while positive samples were found in 56 (42.4%), 64 (48.5%), 98 (74.2%), 28 (21.2%) and 81 (61.4%) of the patients by culture, HpSA, PCR, stool PCR and FISH methods, respectively. The results of the culture, biopsy PCR, HpSA and FISH tests, with the exception of the stool PCR, were found to correlate with the histological examination as a gold standard.
CONCLUSION: The HpSA test is a rapid, simple, and noninvasive test for monitoring therapy. FISH is an accurate, rapid, cost-effective, and easy-to-use test for H. pylori detection.
-
Citation: Aktepe OC, Çiftçi İH, Şafak B, Uslan İ, Dilek FH. Five methods for detection of
Helicobacter pylori in the Turkish population. World J Gastroenterol 2011; 17(47): 5172-5176 - URL: https://www.wjgnet.com/1007-9327/full/v17/i47/5172.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i47.5172
In 1984, Marshall and Warren[1] reported the discovery of a bacterium, which was subsequently named Helicobacter pylori (H. pylori)[2], whose habitat was the human gastric mucosa. This bacterium has been shown to play a role in gastritis, peptic ulcer disease, and gastric malignancies[3-5]. Colonization of the human gastric mucosa induces chronic gastritis and peptic ulcer disease[3,4]. In addition, H. pylori plays a role in the etiology of gastric cancer and cancer of the mucosa-associated lymphoid tissue[5].
The accurate detection of H. pylori is essential for the management of patients and for the eradication of the bacterium following treatment. Since the discovery of H. pylori, several diagnostic methods have become available for determining the presence of H. pylori infection. These tests can be assessed by invasive and noninvasive methods[6]. Assessment of H. pylori infection is based on noninvasive tests, such as serological methods, C urea breath test, and bacterial DNA sequences or bacterial antigen detection in stool by the H. pylori stool antigen (HpSA) test[7]. Under many circumstances, noninvasive testing is preferred. These tests are attractive because of their simplicity and the ability to provide test results within a few minutes after administration, in a physician’s office. In contrast, the direct detection and culturing of H. pylori for the diagnosis of infection requires gastric biopsy specimens obtained from invasive gastroduodenoscopy[5]. Culture methods require an incubation period of at least 4-7 d. However, it is important to note that H. pylori is a fastidious microorganism and is affected by environmental conditions[8,9]. The presence of H. pylori or resistance to antimicrobials can be investigated on gastric tissue samples with molecular methods, such as polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH).
The aim of this study was to compare culture analysis, HpSA test, PCR and FISH to histological examination for the detection of H. pylori.
One hundred and thirty-two consecutive adult dyspeptic patients receiving diagnostic endoscopy at the department of gastroenterology were enrolled in this study. Written informed consent was obtained from all of the patients before endoscopy, and sample collection and approval by the Local Ethical Committee was taken prior to initiation of the project. Patients who underwent partial or complete gastrectomy, those with prior H. pylori eradication therapy, or those who were treated with any antibiotics, colloidal bismuth compounds, proton pump inhibitors, or H2 receptor blockers within the past 4 wk were excluded from the study.
Endoscopy was performed with a PentaxFG-29W (Pentax, Germany) on patients after an overnight fast. Four gastric biopsies (two from the antrum and two from the corpus) were taken from each patient.
Two gastric biopsy specimens, one from the antrum and one from the corpus, were obtained and placed in Stuart’s transport medium. Cooled samples were transported to the laboratory of the Department of Microbiology within 1-2 h after procurement, as previously described[10]. Specimens were inoculated onto brain-heart infusion agar supplemented with sheep blood (10%), vancomycin (10 mg/L), trimethoprim lactate (5 mg/L), cefsoludin (5 mg/L), and amphotericin (5 mg/L). The plates were microaerobically incubated using CampyGen (Oxoid, United Kingdom) at 37 °C for up to 7 d. Positive cultures were identified by colony formation and Gram stain morphology as well as positive catalase, oxidase, and urease tests.
Two gastric biopsy specimens, one from the antrum and one from the corpus, were fixed in 10% formalin in separate containers and were sent to the Pathology Laboratory. Samples were embedded in paraffin wax, cut at 5 μm thickness, and stained with modified giemsa and hematoxylin and eosin. Histological evaluation of the samples for H. pylori was performed according to the Modified Sydney system[11]. The pathologist was unaware of the patients’ clinical conditions and other test results.
Stool samples were tested for H. pylori antigen by the mo-noclonal antigen FemtoLab H. pylori Cnx kits (Connex GmbH, Martinsried, Germany) using the manufacturer’s protocol. Approximately 0.1 g of stool sample was added to vials that contained 1 mL of sample diluent and then emulsified by vortexing for 15 s. The tip of the vial was snapped off and 50 μL sample and 50 μL conjugate were added to the test well. The strip was rinsed after incubation for exactly (60 ± 5) min at ambient temperature. After washing, 100 μL substrate was added and then incubated for 10 min. Finally, the stop solution was added and the samples were analyzed on a spectrophotometer at a wavelength of 450 nm.
Gastric biopsies from all of the study subjects were stored at temperatures at or below -70 °C until use. Each biopsy was digested with tissue extraction buffer at 55 °C for 3 h. Then, 200 μL phenol was added to the tissue lysate to extract genomic DNA. H. pylori genomic DNA from stool samples was extracted according to Gramley et al[12]. Genomic DNA was subsequently quantified by PCR with 16S rRNA. Amplified fragments were separated on a 1% agarose gel and visualized under ultraviolet light.
Formalin-fixed paraffin-embedded gastric biopsies were sectioned and dehydrated. The sections were then air-dried and hybridized using the commercially available test system Seafast®H. pylori Combi Kit (Izinta, Hungary) according to the manufacturer’s instructions. The oligonucleotide probe Hpy-1, which targets a specific sequence of 16S rRNA from H. pylori, was hybridized to the sections. Evaluation was performed with a fluorescent microscope equipped with a filter for green fluorescence (Nikon Eclipse 600, Japan).
The χ2 and Pearson correlation analysis were conducted and the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), P value, r value, odds ratio (OR) and relative risk (RR) were calculated using standard formulas for data using SPSS v. 10.0 (IBM, United States).
H. pylori was identified by histological examination in 85/132 (64.4%) of the patients, while 47/132 (35.6%) of the patients were classified as H. pylori negative. Furthermore, positive results were obtained in 56 (42.4%), 64 (48.5%), 98 (74.2%), 28 (21.2%) and 81 (61.4%) of patients by the culture method, HpSA analysis, PCR, stool PCR and FISH, respectively. Histological examination results were evaluated by the gold standard, and specificity, sensitivity, PPV and NPV were calculated for each test (Table 1). A high number of false-positive results was observed in the biopsy PCR (23/98; 23.4%). However, a higher rate of false-negative results was obtained with the culture method (33/76; 43.4%). The culture method, biopsy PCR, HpSA and FISH tests were found to correlate with the Pearson correlation analysis. Similarly, these tests were statistically comparable to the histological examination based on the P value with the χ2 test. In contrast, the stool PCR test did not correlate or have a significant P value. These data are summarized in Table 2.
Method | Sensitivity | Specificity | PPV | NPV | OR | RR |
Culture | 0.6118 | 0.9149 | 0.9286 | 0.4342 | 16.94 | 2.14 |
HpSA | 0.7222 | 0.6667 | 0.8125 | 0.4545 | 5.20 | 1.79 |
Biopsy PCR | 0.8824 | 0.5106 | 0.7653 | 0.2941 | 7.83 | 2.60 |
Stool PCR | 0.2118 | 0.7872 | 0.6429 | 0.6442 | 0.99 | 1.00 |
FISH | 0.9294 | 0.9574 | 0.9753 | 0.1176 | 296.25 | 8.29 |
There are currently several different diagnostic tests that exist for detecting H. pylori infection. Each test has its own merits and demerits in terms of indication, sensitivity, specificity, cost and time. Several studies have examined the diagnostic performance of invasive and noninvasive methods[6,7,9,12,13]. However, these studies were biased or demonstrated a lack of agreement[13]. One possible reason for the discrepancies in diagnostic performance might be due to the selection of various reference methods. Currently, there is no established method to provide a definitive or standard diagnosis of H. pylori infection. The selection of tests or the use of a combination of tests without identifying any one specific test as a reference standard can introduce bias[14].
One limit of histological detection of H. pylori in gastric biopsy specimens is interobserver variability in assessment[15,16]. A meta-analysis has reported that histological examination results have an approximate sensitivity of 0.70 and specificity of 0.90[17]. This may be due to the discrepancies in the evaluation of features of H. pylori or the observations of the pathologist, because pathology results are based on subjective interpretation of different features and classification. Various studies on the reproducibility of histopathological data have reached a similar conclusion. However, the histological examination of the gastric biopsy specimen is accepted as the gold standard for the diagnosis of H. pylori[18]. In this study, histological examination resulted in 64.4% positivity for H. pylori, which showed a good correlation with the positive detection rates of other methods, with the exception of stool PCR.
Culturing biopsy specimens cannot be routinely used because it is time consuming and very difficult to maintain strict anaerobic conditions. However, bacterial cultures can surely provide specific results and informative data. Gisbert and Abraria have reported three studies with culture sensitivity of 0.45 and specificity of 0.98 in 2006[17]. Similarly, we found that the culture sensitivity and specificity was 0.61 and 0.91, respectively. In addition, the statistical analysis showed a PPV of 0.93, NPV of 0.43, OR of 16.94, and RR of 2.14 compared to histological examination.
The HpSA test is available and recommended in the Maastricht 2-2000 Consensus Report[19] for the pretreatment diagnosis of H. pylori infection and confirmation of a H. pylori cure following treatment. In a Japanese study, the HpSA test had a reported sensitivity of 93.9% and specificity of 95.7%, compared to a diagnosis of infection based on histological examination[20]. However, Blanco et al[21] have observed that another stool antigen test showed a low sensitivity (75%-79%), in patients with H. pylori infection who were tested after erradication therapy. We studied the accuracy of the HpSA test in the Turkish population. The HpSA test had a sensitivity of 0.72, specificity of 0.67, accuracy of 0.77, PPV of 0.81, OR of 5.20 and RR of 1.79. Thus, the HpSA test results had a low but acceptable correlation with the histological examination.
It has been reported that the FISH method is an accurate, inexpensive, rapid test for the detection of H. pylori in paraffin-embedded gastric biopsy samples, with a high sensitivity and specificity[22-24]. In addition, it can be applied to fresh gastric tissue samples and H. pylori isolates from culture[25]. In this study, the FISH method had a strong correlation with the histological examination and exhibited a sensitivity of 0.93, specificity of 0.96, accuracy of 0.94, PPV of 0.98, OR of 296.25 and RR of 8.29. Furthermore, the FISH method may be a very useful H. pylori diagnostic tool in microbiology in the future.
In gastric tissue, the presence of H. pylori and resistance genes can be investigated by PCR. It has a high sensitivity and specificity, and can be used as a follow-up assessment after therapy[26,27]. In this study, biopsy PCR studies had a sensitivity of 0.88, specificity of 0.51, accuracy of 0.75, PPV of 0.77, OR of 7.83 and RR of 2.60. Moreover, we found that the specificity value was particularly low for the biopsy PCR results. However, there was a discrepancy between our study and previous reports in terms of the specificity of H. pylori detection[28,29]. Lunet et al[28] have reported a difference in H. pylori positivity by histology vs PCR from different populations, in Mozambique and Portugal of 63.7% vs 93.1% and 95.3% vs 98.1%, respectively. Two possibilities could explain this conflicting result. First, a low density of H. pylori colonization may explain the histological results. Alternatively, the PCR results may be reliable because of the use of a specific primer for the particular population.
The stool PCR results had a very low sensitivity and OR (0.21 and 0.99) and had no significant correlation with the histological examination. Previous studies and our data clearly indicate that there is no clinical value in the determination of H. pylori in human feces by PCR because of insufficient sensitivity, specificity, and accuracy[30].
There are a variety of tests available for the diagnosis of H. pylori infection. Therefore, it is important that laboratories choose the test or tests that are appropriate for the conditions of the laboratories, patient numbers, costs, and account for the need to prepare their own diagnostic algorithms.
In conclusion, the culture, biopsy PCR, HpSA test, and FISH methods for the detection of H. pylori in this study, with the exception of stool PCR, were found to correlate with histological examination as a gold standard. In addition, there was a conflicting result on biopsy PCR data when compared to histological examination. The HpSA test is a rapid, simple, and noninvasive test with acceptable results that can be used for monitoring therapy. The FISH method is an accurate, rapid, cost-effective and easy-to-use test for the detection of H. pylori, and also allows for the simultaneous determination of antibiotic resistance in the same gastric tissue. Therefore, histopathological examination as a gold standard and the FISH test may be the preferred methods to use together for the precise detection of H. pylori.
Helicobacter pylori (H. pylori) plays a role in gastritis, peptic ulcer disease and also gastric malignancies such as gastric cancer and cancer of the mucosa-associated lymphoid tissue. The accurate detection of H. pylori is essential for the management of patients and eradication of the bacteria following treatment.
Since the discovery of H. pylori, several diagnostic methods have been become available for determining the presence of H. pylori infection. However, there is no established method to provide a definitive or standard diagnosis of H. pylori infection.
The fluorescence in situ hybridization (FISH) test is an accurate, rapid, inexpensive and easy-to-use method for the detection of H. pylori, and allows determination of antibiotic resistance in the same gastric tissue simultaneously. In this study, FISH correlated well with histological examination. Therefore, histological examination and the FISH test may be preferred together for the precise detection of H. pylori.
This study suggests that, laboratories choose the test or tests that are appropriate for their own conditions, patient numbers and costs, and have to prepare their own diagnostic algorithms.
For the detection of H. pylori, culture, H. pylori stool antigen test, polymerase chain reaction and FISH were used with histological examination.
This was an interesting study, although a few problems need to be resolved before publication. The most important point is the reliability of their gold standard. The reasons for the false-positive and false-negative results of each test should be discussed further.
Peer reviewer: Dr. Masayoshi Ito, Department of Endoscopy, Yotsuya Medical Cube, Tokyo 102-0084, Japan
S- Editor Sun H L- Editor Kerr C E- Editor Li JY
1. | Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311-1315. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3302] [Cited by in F6Publishing: 3182] [Article Influence: 79.6] [Reference Citation Analysis (1)] |
2. | Goodwin CS, Armstrong JA. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis. 1990;9:1-13. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 90] [Cited by in F6Publishing: 96] [Article Influence: 2.8] [Reference Citation Analysis (0)] |
3. | Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology. 1992;102:720-727. [PubMed] [Cited in This Article: ] |
4. | Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev. 1997;10:720-741. [PubMed] [Cited in This Article: ] |
5. | European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut. 1997;41:8-13. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 679] [Cited by in F6Publishing: 669] [Article Influence: 24.8] [Reference Citation Analysis (1)] |
6. | Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995;109:136-141. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 330] [Cited by in F6Publishing: 309] [Article Influence: 10.7] [Reference Citation Analysis (0)] |
7. | Vaira D, Malfertheiner P, Mégraud F, Axon AT, Deltenre M, Gasbarrini G, O'Morain C, Pajares Garcia JM, Quina M, Tytgat GN. Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol. 2000;95:925-929. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 3.2] [Reference Citation Analysis (0)] |
8. | Forbes B, Sahm DF, Weissfeld AS. Campylobacter, Arcobacter, and Helicobacter. Philadelphia: Mosby 2002; 474-481. [Cited in This Article: ] |
9. | Rüssmann H, Kempf VA, Koletzko S, Heesemann J, Autenrieth IB. Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J Clin Microbiol. 2001;39:304-308. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 2.6] [Reference Citation Analysis (0)] |
10. | Tüzün Y, Bayan K, Yilmaz S, Dursun M, Ozekinci T. The prevalence of primary and secondary Helicobacter pylori resistance to clarithromycin and probable contributing cofactors: data from southeastern Anatolia. Hepatogastroenterology. 2008;55:289-293. [PubMed] [Cited in This Article: ] |
11. | Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3221] [Cited by in F6Publishing: 3442] [Article Influence: 122.9] [Reference Citation Analysis (3)] |
12. | Gramley WA, Asghar A, Frierson HF, Powell SM. Detection of Helicobacter pylori DNA in fecal samples from infected individuals. J Clin Microbiol. 1999;37:2236-2240. [PubMed] [Cited in This Article: ] |
13. | Thijs JC, van Zwet AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F, Luijt DS, Meyer BC, Kleibeuker JH. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol. 1996;91:2125-2129. [PubMed] [Cited in This Article: ] |
14. | Jamart J. Incorrect gold standard in diagnostic tests for Helicobacter pylori. Am J Gastroenterol. 1997;92:1071. [PubMed] [Cited in This Article: ] |
15. | Talebkhan Y, Mohammadi M, Rakhshani N, Abdirad A, Fayaz Moughadam K, Fereidooni F. Interobserver variations in histopathological assessment of gastric pathology. Pathology. 2009;41:428-432. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis (0)] |
16. | Aydin O, Egilmez R, Karabacak T, Kanik A. Interobserver variation in histopathological assessment of Helicobacter pylori gastritis. World J Gastroenterol. 2003;9:2232-2235. [PubMed] [Cited in This Article: ] |
17. | Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101:848-863. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 139] [Cited by in F6Publishing: 128] [Article Influence: 7.1] [Reference Citation Analysis (0)] |
18. | Tepes B, Ferlan-Marolt V, Jutersek A, Kavcic B, Zaletel-Kragelj L. Interobserver agreement in the assessment of gastritis reversibility after Helicobacter pylori eradication. Histopathology. 1999;34:124-133. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
19. | Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002;16:167-180. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 846] [Cited by in F6Publishing: 834] [Article Influence: 37.9] [Reference Citation Analysis (1)] |
20. | Ohkura R, Miwa H, Murai T, Nagahara A, Ohta K, Sato K, Yamada T, Sato N. Usefulness of a novel enzyme immunoassay for the detection of Helicobacter pylori in feces. Scand J Gastroenterol. 2000;35:49-53. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis (0)] |
21. | Blanco S, Forné M, Lacoma A, Prat C, Cuesta MA, Fuenzalida L, Viver JM, Domínguez J. Evaluation of a latex agglutination test (PYLOGEN) for the detection of Helicobacter pylori in stool specimens. Diagn Microbiol Infect Dis. 2009;63:349-353. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
22. | Tajbakhsh S, Samarbaf-Zadeh AR, Moosavian M. Comparison of fluorescent in situ hybridization and histological method for the diagnosis of Helicobacter pylori in gastric biopsy samples. Med Sci Monit. 2008;14:BR183-BR187. [PubMed] [Cited in This Article: ] |
23. | Morris JM, Reasonover AL, Bruce MG, Bruden DL, McMahon BJ, Sacco FD, Berg DE, Parkinson AJ. Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections. J Clin Microbiol. 2005;43:3494-3496. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis (0)] |
24. | Can F, Yilmaz Z, Demirbilek M, Bilezikci B, Kunefeci G, Atac FB, Selcuk H, Arslan H, Boyacioglu S, Sahin FI. Diagnosis of Helicobacter pylori infection and determination of clarithromycin resistance by fluorescence in situ hybridization from formalin-fixed, paraffin-embedded gastric biopsy specimens. Can J Microbiol. 2005;51:569-573. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
25. | Yilmaz O, Demiray E. Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy. World J Gastroenterol. 2007;13:671-675. [PubMed] [Cited in This Article: ] |
26. | Sezgin O, Aslan G, Altintaş E, Tezcan S, Serin MS, Emekdaş G. Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey. Turk J Gastroenterol. 2008;19:163-167. [PubMed] [Cited in This Article: ] |
27. | Agudo S, Pérez-Pérez G, Alarcón T, López-Brea M. High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain. J Clin Microbiol. 2010;48:3703-3707. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 85] [Cited by in F6Publishing: 95] [Article Influence: 6.8] [Reference Citation Analysis (0)] |
28. | Lunet N, Peleteiro B, Carrilho C, Figueiredo C, Azevedo A. Sensitivity is not an intrinsic property of a diagnostic test: empirical evidence from histological diagnosis of Helicobacter pylori infection. BMC Gastroenterol. 2009;9:98. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
29. | de Martel C, Plummer M, van Doorn LJ, Vivas J, Lopez G, Carillo E, Peraza S, Muñoz N, Franceschi S. Comparison of polymerase chain reaction and histopathology for the detection of Helicobacter pylori in gastric biopsies. Int J Cancer. 2010;126:1992-1996. [PubMed] [Cited in This Article: ] |
30. | Keenan JI, Beaugie CR, Jasmann B, Potter HC, Collett JA, Frizelle FA. Helicobacter species in the human colon. Colorectal Dis. 2010;12:48-53. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis (0)] |